+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Drug Delivery Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Drug Delivery Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083895
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Delivery Market grew from USD 1.82 billion in 2024 to USD 1.94 billion in 2025. It is expected to continue growing at a CAGR of 6.46%, reaching USD 2.66 billion by 2030.

The drug delivery sector stands at the confluence of scientific innovation, patient-centric care, and rigorous regulatory oversight. Over the past decade, advances in materials science, biotechnology, and engineering have propelled new carrier systems and routes of administration, enabling therapies to reach target tissues more efficiently while minimizing side effects. As the industry pivots toward personalized medicine, precision dosing and adaptive delivery platforms have become critical to unlocking the full therapeutic potential of biologics, small molecules, and combination products. Concurrently, payers and health authorities demand robust evidence of safety, efficacy, and cost-effectiveness for novel delivery solutions, heightening the need for comprehensive development strategies.

Against this backdrop, stakeholders-from pharmaceutical developers to medical device manufacturers-must navigate a complex ecosystem of dynamic patient needs, evolving regulatory pathways, and emerging market pressures. This executive summary synthesizes the most impactful trends, competitive landscapes, and strategic imperatives shaping the future of drug delivery. By examining transformative shifts, tariff headwinds, deep segmentation insights, regional dynamics, and key corporate maneuvers, this analysis equips decision-makers with the clarity required to chart a path forward in 2025 and beyond.

Transformative Shifts Reshaping Drug Delivery

Innovation continues to accelerate across drug delivery, driven by several transformative shifts reshaping the market’s trajectory.

First, the rise of biologics and complex molecules has fueled demand for sophisticated carrier systems-ranging from nano-enabled liposomal formulations to implantable devices-that protect labile compounds and release active agents in a controlled or pulsatile fashion. Simultaneously, digital health integration and connectivity have enabled real-time monitoring and dose adjustment, transforming passive delivery platforms into intelligent, patient-centric ecosystems.

Second, regulatory agencies globally are embracing adaptive pathways and expedited review programs for breakthrough therapies, incentivizing the co-development of novel delivery mechanisms. This regulatory agility has lowered barriers to market entry but also necessitates stringent comparability studies and post-market surveillance to ensure long-term safety.

Third, sustainability and cost containment have driving forces behind materials innovation and circular manufacturing practices, compelling companies to adopt eco-friendly polymers and modular production lines. Finally, the convergence of telemedicine, wearable sensors, and personalized dosing algorithms is forging holistic care models that extend beyond the clinic, fostering greater adherence and improved patient outcomes.

Collectively, these shifts underscore a landscape in flux, where technological integration, regulatory evolution, and patient empowerment converge to redefine drug delivery.

Assessing the Cumulative Impact of US Tariffs in 2025

In 2025, newly enacted U.S. tariffs on active pharmaceutical ingredients, device components, and certain polymers are poised to exert a cumulative impact across the drug delivery value chain. Manufacturers reliant on overseas sourcing of advanced polymers for controlled release matrices or specialized metals for implantable micro-pumps will face margin compression unless service providers and distributors renegotiate supply agreements or seek alternative materials.

Tariffs levied on nano-carrier excipients and electroporation equipment may elevate production costs for emerging technologies, incentivizing companies to reassess regional manufacturing footprints. To mitigate exposure, several industry leaders are exploring near-shoring strategies and dual-source procurement, while others are fast-tracking process intensification initiatives to reduce material waste and shorten cycle times.

Price adjustments may be required to preserve revenue targets, but payers are likely to challenge cost increases without demonstrable clinical or economic value. Consequently, organizations must intensify value-based dialogues with stakeholders, bolster real-world evidence generation, and collaborate with regulators to secure tariff exemptions for critical therapy-enabling components.

By proactively addressing tariff-driven headwinds through strategic sourcing, supply chain resilience, and rigorous cost-benefit communication, drug delivery innovators can safeguard profitability and maintain momentum in an increasingly protectionist environment.

Key Segmentation Insights Driving Market Dynamics

A nuanced understanding of market segmentation reveals where growth and differentiation converge. When considering drug delivery technology, the landscape includes controlled release systems-comprising grafting polymers, matrix constructs, and reservoir architectures-alongside local delivery approaches featuring colonic release devices, implantable implants, and intraocular inserts. Nano-enabled delivery harnesses liposomes, nanocapsules, and nanoparticles to enhance bioavailability, while pulsatile platforms encompass both multiple-unit and single-unit designs. Transdermal modalities leverage electroporation, microneedles, and patch systems to facilitate noninvasive dosing.

From a formulation perspective, inhalation options span dry powder inhalers, metered dose inhalers, and nebulizers, complementing injectable formats that include intramuscular, intravenous, and subcutaneous routes. Oral administration is manifested through capsules, suspensions, syrups, and tablets, while topical forms such as creams, gels, and ointments continue to address dermatological needs.

Route of administration further differentiates the market into nasal sprays and oral inhalers for inhalation delivery; central lines and vein-path baselines for intravenous infusions; corneal inserts and eye drops for ocular therapies; as well as extended-release and immediate-release products for oral dosing, plus adhesive and matrix systems for transdermal applications.

Therapeutic areas drive specific demands: oncology therapeutic delivery is segmented into breast, lung, and prostate cancer; diabetes therapies focus on both type 1 and type 2 management; cardiovascular, neurological, and other specialty domains add further complexity. End-user channels span laboratory-based and point-of-care diagnostic centers, personalized delivery kits and wearable devices in home care settings, and inpatient/outpatient services within hospital networks.

Finally, device type segmentation includes advanced systems such as closed-loop and smart device platforms, portable insulin pumps integrating continuous glucose monitoring or tethered pump configurations, and wearable technologies that range from adhesive patch devices to infusion-based wearables. This granular breakdown guides targeted innovation pathways and investment prioritization.

Regional Trends Highlighting Growth Opportunities

Regional dynamics underscore stark contrasts in adoption patterns and strategic priorities. In the Americas, mature regulatory frameworks, high healthcare expenditure, and extensive reimbursement coverage have catalyzed widespread uptake of advanced parenteral and implantable platforms, with a spotlight on oncology and chronic disease management.

Across Europe, the Middle East and Africa, market growth is propelled by harmonized regulatory standards under the European Medicines Agency, burgeoning interest in localized manufacturing hubs, and government initiatives to expand access to innovative delivery systems for cancer, cardiovascular, and metabolic disorders.

Finally, the Asia-Pacific region exhibits the fastest expansion, driven by rising prevalence of chronic illnesses, expanding healthcare infrastructure, and favorable policy frameworks to attract foreign direct investment in medical devices and pharmaceutical manufacturing. Local partnerships and technology transfers are accelerating the deployment of transdermal, inhalation, and nano-enabled platforms, making APAC a key battleground for growth.

Leading Companies Steering Industry Innovation

Industry leadership is shaped by established multinationals and nimble specialists alike. Antares Pharma continues to refine autoinjector technology for biologics, while Halozyme Therapeutics advances recombinant human hyaluronidase formulations to enhance subcutaneous delivery. B. Braun SE and Baxter International deploy modular infusion systems designed for closed-loop operation and reduced hospital stays.

Becton, Dickinson and Company innovates safety-engineered devices that mitigate needlestick injuries, whereas Enable Injections pioneers controlled-release microparticle platforms. Gerresheimer AG leverages glass and polymer expertise to produce prefilled syringes and vials that meet stringent quality standards. Johnson & Johnson Services extends its portfolio with smart wearable injectors linked to digital health ecosystems, and Kindeva Drug Delivery optimizes orodispersible films for patient convenience.

Koninklijke Philips N.V. integrates diagnostic sensors into drug delivery devices, while Merck KGaA explores polymeric nanoparticles for targeted oncology treatment. Novartis AG and Sanofi S.A. partner with device innovators to co-develop combination products, enhancing therapeutic precision. Insulet Corporation’s tubeless pumps and OraSure Technologies’ point-of-care platforms underscore the shift toward self-administration. Finally, Oxford BioMedica pioneers viral vector systems for gene therapies, illustrating the breadth of innovation across the sector.

Actionable Recommendations for Industry Leaders

  • Invest in modular manufacturing and regional production hubs to mitigate tariff exposure and shorten supply chains, ensuring continuity of critical component supply.
  • Forge strategic alliances with material science firms to develop sustainable excipients and polymers that balance performance with regulatory compliance.
  • Leverage digital health platforms and connected devices to generate real-world evidence, supporting value-based reimbursement discussions and enhancing patient adherence.
  • Prioritize interoperability standards and cybersecurity protocols in smart delivery systems to safeguard patient data and streamline integration with electronic health records.
  • Expand into emerging markets through localized partnerships, tailored pricing strategies, and regulatory support to capture growing demand for cost-effective therapies.
  • Implement adaptive clinical trial designs and accelerated regulatory pathways for breakthrough delivery technologies to reduce time-to-market while maintaining safety standards.
  • Embrace patient-centric design principles-such as user-friendly administration, dose flexibility, and minimal invasiveness-to differentiate products in crowded therapeutic areas.

Conclusion: Navigating the Future of Drug Delivery

As drug delivery continues to evolve at the intersection of technology, regulation, and patient expectations, stakeholders must adopt an integrated approach to innovation. By aligning R&D investments with clear clinical needs, reinforcing supply chain resilience, and fostering collaborative ecosystems between pharma, device manufacturers, and payers, companies can accelerate the translation of novel delivery solutions into clinical practice.

The journey ahead demands unwavering focus on demonstrating tangible clinical benefits and health economic value, particularly in the context of pricing pressures and reimbursement scrutiny. Those organizations that deftly navigate tariff headwinds, harness digital platforms for real-world data, and embrace sustainable materials will emerge as market leaders. Ultimately, success hinges on delivering precision therapies in a manner that balances efficacy, safety, cost, and patient convenience.

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Controlled Release Systems
    • Grafting Polymers
    • Matrix Systems
    • Reservoir Systems
  • Local Drug Delivery Systems
    • Colonic Release Devices
    • Implantable Devices
    • Intraocular Devices
  • Nano-Enabled Drug Delivery
    • Liposomes
    • Nanocapsules
    • Nanoparticles
  • Pulsatile Drug Delivery Systems
    • Multiple-Unit Systems
    • Single-Unit Systems
  • Transdermal Delivery Systems
    • Electroporation
    • Microneedles
    • Patches
  • Inhalation Formulations
    • Dry Powder Inhalers
    • Metered Dose Inhalers
    • Nebulizers
  • Injectable Formulations
    • Intramuscular
    • Intravenous
    • Subcutaneous
  • Oral Formulations
    • Capsules
    • Suspensions
    • Syrups
    • Tablets
  • Topical Formulations
    • Creams
    • Gels
    • Ointments
  • Inhalation Delivery
    • Nasal Sprays
    • Oral Inhalers
  • Intravenous Delivery
    • Central Line
    • Vein Path Baseline
  • Ocular Delivery
    • Corneal Inserts
    • Eye Drops
  • Oral Delivery
    • Extended Release
    • Immediate Release
  • Transdermal Delivery
    • Adhesive Systems
    • Matrix Systems
  • Cancer
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Diabetes
    • Type 1
    • Type 2
  • Diagnostic Centers
    • Laboratory-Based
    • Point-Of-Care
  • Home Care
    • Personalized Delivery Kits
    • Wearable Delivery Devices
  • Hospitals
    • Inpatient Facilities
    • Outpatient Services
  • Advanced Systems
    • Closed Loop Systems
    • Smart Devices
  • Portable Insulin Pumps
    • Continuous Glucose Monitoring
    • Tethered Pumps
  • Wearable Devices
    • Adhesive Patch Devices
    • Infusion Devices

This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Drug Delivery Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Johnson & Johnson Services Inc.
  • Kindeva Drug Delivery
  • Koninklijke Philips N.V.
  • Merck KGaA
  • Novartis AG
  • nsulet Corporation
  • OraSure Technologies, Inc.
  • Oxford BioMedica PLC
  • Sanofi S.A.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Delivery Market, by Drug Delivery Technology
8.1. Introduction
8.2. Controlled Release Systems
8.2.1. Grafting Polymers
8.2.2. Matrix Systems
8.2.3. Reservoir Systems
8.3. Local Drug Delivery Systems
8.3.1. Colonic Release Devices
8.3.2. Implantable Devices
8.3.3. Intraocular Devices
8.4. Nano-Enabled Drug Delivery
8.4.1. Liposomes
8.4.2. Nanocapsules
8.4.3. Nanoparticles
8.5. Pulsatile Drug Delivery Systems
8.5.1. Multiple-Unit Systems
8.5.2. Single-Unit Systems
8.6. Transdermal Delivery Systems
8.6.1. Electroporation
8.6.2. Microneedles
8.6.3. Patches
9. Drug Delivery Market, by Drug Formulation
9.1. Introduction
9.2. Inhalation Formulations
9.2.1. Dry Powder Inhalers
9.2.2. Metered Dose Inhalers
9.2.3. Nebulizers
9.3. Injectable Formulations
9.3.1. Intramuscular
9.3.2. Intravenous
9.3.3. Subcutaneous
9.4. Oral Formulations
9.4.1. Capsules
9.4.2. Suspensions
9.4.3. Syrups
9.4.4. Tablets
9.5. Topical Formulations
9.5.1. Creams
9.5.2. Gels
9.5.3. Ointments
10. Drug Delivery Market, by Route of Administration
10.1. Introduction
10.2. Inhalation Delivery
10.2.1. Nasal Sprays
10.2.2. Oral Inhalers
10.3. Intravenous Delivery
10.3.1. Central Line
10.3.2. Vein Path Baseline
10.4. Ocular Delivery
10.4.1. Corneal Inserts
10.4.2. Eye Drops
10.5. Oral Delivery
10.5.1. Extended Release
10.5.2. Immediate Release
10.6. Transdermal Delivery
10.6.1. Adhesive Systems
10.6.2. Matrix Systems
11. Drug Delivery Market, by Therapeutic Area
11.1. Introduction
11.2. Cancer
11.2.1. Breast Cancer
11.2.2. Lung Cancer
11.2.3. Prostate Cancer
11.3. Cardiovascular Diseases
11.4. Central Nervous System Disorders
11.5. Diabetes
11.5.1. Type 1
11.5.2. Type 2
12. Drug Delivery Market, by End-User
12.1. Introduction
12.2. Diagnostic Centers
12.2.1. Laboratory-Based
12.2.2. Point-Of-Care
12.3. Home Care
12.3.1. Personalized Delivery Kits
12.3.2. Wearable Delivery Devices
12.4. Hospitals
12.4.1. Inpatient Facilities
12.4.2. Outpatient Services
13. Drug Delivery Market, by Device Type
13.1. Introduction
13.2. Advanced Systems
13.2.1. Closed Loop Systems
13.2.2. Smart Devices
13.3. Portable Insulin Pumps
13.3.1. Continuous Glucose Monitoring
13.3.2. Tethered Pumps
13.4. Wearable Devices
13.4.1. Adhesive Patch Devices
13.4.2. Infusion Devices
14. Americas Drug Delivery Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Drug Delivery Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Drug Delivery Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
17.3.2. B. Braun SE
17.3.3. Baxter International Inc.
17.3.4. Becton, Dickinson and Company
17.3.5. Enable Injections, Inc.
17.3.6. Gerresheimer AG
17.3.7. Johnson & Johnson Services Inc.
17.3.8. Kindeva Drug Delivery
17.3.9. Koninklijke Philips N.V.
17.3.10. Merck KGaA
17.3.11. Novartis AG
17.3.12. nsulet Corporation
17.3.13. OraSure Technologies, Inc.
17.3.14. Oxford BioMedica PLC
17.3.15. Sanofi S.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG DELIVERY MARKET MULTI-CURRENCY
FIGURE 2. DRUG DELIVERY MARKET MULTI-LANGUAGE
FIGURE 3. DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY GRAFTING POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY MATRIX SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY RESERVOIR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY COLONIC RELEASE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY INTRAOCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DELIVERY MARKET SIZE, BY NANOCAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DELIVERY MARKET SIZE, BY MULTIPLE-UNIT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DELIVERY MARKET SIZE, BY SINGLE-UNIT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DELIVERY MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DELIVERY MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DELIVERY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DELIVERY MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG DELIVERY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG DELIVERY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DELIVERY MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DELIVERY MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG DELIVERY MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DELIVERY MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG DELIVERY MARKET SIZE, BY VEIN PATH BASELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DELIVERY MARKET SIZE, BY CORNEAL INSERTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG DELIVERY MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG DELIVERY MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRUG DELIVERY MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADHESIVE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRUG DELIVERY MARKET SIZE, BY MATRIX SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DRUG DELIVERY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG DELIVERY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DRUG DELIVERY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG DELIVERY MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG DELIVERY MARKET SIZE, BY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL DRUG DELIVERY MARKET SIZE, BY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL DRUG DELIVERY MARKET SIZE, BY LABORATORY-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG DELIVERY MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL DRUG DELIVERY MARKET SIZE, BY PERSONALIZED DELIVERY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG DELIVERY MARKET SIZE, BY WEARABLE DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL DRUG DELIVERY MARKET SIZE, BY INPATIENT FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG DELIVERY MARKET SIZE, BY OUTPATIENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG DELIVERY MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL DRUG DELIVERY MARKET SIZE, BY SMART DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL DRUG DELIVERY MARKET SIZE, BY TETHERED PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADHESIVE PATCH DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL DRUG DELIVERY MARKET SIZE, BY INFUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 197. CANADA DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. CANADA DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. CANADA DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 200. CANADA DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 201. CANADA DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 202. CANADA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. CANADA DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. CANADA DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 205. CANADA DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 206. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 207. CANADA DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 208. CANADA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. CANADA DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 210. CANADA DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 211. CANADA DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 212. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 213. CANADA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 214. CANADA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 215. CANADA DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 216. CANADA DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 217. CANADA DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. CANADA DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 219. CANADA DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 220. CANADA DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. CANADA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 222. CANADA DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 223. CANADA DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 224. CANADA DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 225. MEXICO DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. MEXICO DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. MEXICO DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. MEXICO DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 229. MEXICO DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 230. MEXICO DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. MEXICO DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 232. MEXICO DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 233. MEXICO DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 234. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 235. MEXICO DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 236. MEXICO DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. MEXICO DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 238. MEXICO DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 239. MEXICO DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 240. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 241. MEXICO DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 242. MEXICO DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 243. MEXICO DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 244. MEXICO DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 245. MEXICO DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. MEXICO DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 247. MEXICO DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 248. MEXICO DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 249. MEXICO DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. MEXICO DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 251. MEXICO DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 252. MEXICO DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 266. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 267. UNITED STATES DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 268. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 272. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 273. UNITED STATES DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 275. UNITED STATES DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 276. UNITED STATES DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 278. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 279. UNITED STATES DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 280. UNITED STATES DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 281. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 284. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 286. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 288. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 315. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 316. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 317. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 319. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 320. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 321. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 322. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY INHALATION DELIVERY, 2018-2030 (USD MILLION)
TABLE 324. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 325. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY OCULAR DELIVERY, 2018-2030 (USD MILLION)
TABLE 326. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 327. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 328. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 329. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 330. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 331. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 332. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ADVANCED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY PORTABLE INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY WEARABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 339. CHINA DRUG DELIVERY MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 340. CHINA DRUG DELIVERY MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 341. CHINA DRUG DELIVERY MARKET SIZE, BY LOCAL DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 342. CHINA DRUG DELIVERY MARKET SIZE, BY NANO-ENABLED DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 343. CHINA DRUG DELIVERY MARKET SIZE, BY PULSATILE DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 344. CHINA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL DELIVERY SYSTE

Companies Mentioned

  • Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Johnson & Johnson Services Inc.
  • Kindeva Drug Delivery
  • Koninklijke Philips N.V.
  • Merck KGaA
  • Novartis AG
  • nsulet Corporation
  • OraSure Technologies, Inc.
  • Oxford BioMedica PLC
  • Sanofi S.A.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Drug Delivery Systems Market by Delivery Type, Formulation, Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030 - Product Image

Drug Delivery Systems Market by Delivery Type, Formulation, Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Drug Delivery Devices Market by Route of Administration, Vehicles, Application, End-user - Global Forecast 2025-2030 - Product Image

Drug Delivery Devices Market by Route of Administration, Vehicles, Application, End-user - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Prefilled Syringes, Pen Injectors), Distribution Channel (Retail Pharmacies, Online Pharmacies), Region, and Segment Forecasts, 2025-2030 - Product Image

Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Prefilled Syringes, Pen Injectors), Distribution Channel (Retail Pharmacies, Online Pharmacies), Region, and Segment Forecasts, 2025-2030

  • Report
  • 170 Pages
  • Global
From
Drug and Gene Delivery Devices - Global Strategic Business Report - Product Image

Drug and Gene Delivery Devices - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.